HomeInsightsEPS

Alembic Pharmaceuticals Ltd EPS

Alembic Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

4.5 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

EPS

₹ 32.4

Last updated on: Jan 14, 2025

Key Highlights

  • The Earning per Share of Alembic Pharmaceuticals Ltd is ₹ 32.4 as of 14 Jan 25 .
  • The earning per share of Alembic Pharmaceuticals Ltd changed from ₹ 6.14 to ₹ 7.79 over 6 quarters. This represents a CAGR of 17.20% .

Historical Earning per Share of Alembic Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Alembic Pharmaceuticals Ltd

Market Cap

19,836 Cr

EPS

32.4

P/E Ratio (TTM) *

31.1

P/B Ratio (TTM) *

4.1

Day’s High *

1010.25

Day’s Low

988.05

DTE *

0.2

ROE *

13.2

52 Week High

1296.15

52 Week Low

824.5

ROCE *

12.8

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251009.15
13 Jan 20251003.05
10 Jan 20251008.95
09 Jan 20251054.9
08 Jan 20251064.85
07 Jan 20251091.05
06 Jan 20251062.65
03 Jan 20251052.15
02 Jan 20251050.55
01 Jan 20251048.35

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

19,836

Asset Value

3,379

4.9 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Alembic Pharmaceuticals Ltd3219,836
Sun Pharmaceuticals Industries Ltd464,24,382
Divis Laboratories Ltd691,59,224
Cipla Ltd571,16,943
Dr Reddys Laboratories Ltd631,11,588
Mankind Pharma Ltd511,10,215

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals receives USFDA approval for Brexpiprazole Tablets

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

15 Jan 2025 12:54

News

Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

20 Dec 2024 18:30

News

Alembic Pharma gets USFDA nod for seizure treatment drug

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

20 Dec 2024 14:20

News

Alembic Pharma Panelav unit clears Brazil GMP audit

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency ...

Read more

11 Dec 2024 12:39

News

Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution

Alembic Pharmaceuticals announced that it has received Tentative Approval from the US Food...

Read more

04 Dec 2024 16:41

News

Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride eye drops

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Dec 2024 14:54

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

FAQs for EPS of Alembic Pharmaceuticals Ltd

What is the EPS of Alembic Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Alembic Pharmaceuticals Ltd is 32.4. An EPS is the amount of net income attributed to each share of a common stock.

How is Alembic Pharmaceuticals Ltd EPS calculated?

The EPS of Alembic Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Alembic Pharmaceuticals Ltd report its EPS?

Alembic Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Alembic Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Alembic Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Alembic Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Alembic Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions